R/S-(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[7-bromo-1-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-2-methyl-propyl}-succinamic acid

ID: ALA1835404

PubChem CID: 56666800

Max Phase: Preclinical

Molecular Formula: C30H40BrN5O10

Molecular Weight: 710.58

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CC(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCc2ccc(Br)cc2C1C(=O)N[C@H]1CC(=O)OC1O)C(C)C)C(C)C

Standard InChI: InChI=1S/C30H40BrN5O10/c1-13(2)23(32-15(5)37)27(42)33-19(11-21(38)39)26(41)35-24(14(3)4)29(44)36-9-8-16-6-7-17(31)10-18(16)25(36)28(43)34-20-12-22(40)46-30(20)45/h6-7,10,13-14,19-20,23-25,30,45H,8-9,11-12H2,1-5H3,(H,32,37)(H,33,42)(H,34,43)(H,35,41)(H,38,39)/t19-,20-,23-,24-,25?,30?/m0/s1

Standard InChI Key: CYPFOGHELPCGPU-ZOGZNBLASA-N

Molfile:

     RDKit          2D

 46 48  0  0  0  0  0  0  0  0999 V2000
    4.1458  -18.3808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8132  -17.8932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5576  -17.1036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7308  -17.1049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4784  -17.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2408  -16.4338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5931  -18.1443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1425  -19.2078    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4394  -19.6419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7668  -20.9072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3807  -20.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6720  -20.5772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0973  -20.5931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3708  -21.8225    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9512  -20.9816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2403  -20.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9413  -21.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6522  -22.2270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2205  -22.2109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5217  -20.9656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2502  -19.7362    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8150  -20.5451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0942  -20.9495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8249  -19.7202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0843  -21.7745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1098  -19.2997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6122  -19.7058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1185  -18.4764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6145  -20.5291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3353  -20.9336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0439  -20.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3452  -21.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6343  -22.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0596  -22.1630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0441  -19.6882    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7918  -21.7313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4680  -20.4662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7161  -19.2528    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5212  -22.1161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1978  -20.8591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2195  -21.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9437  -22.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6429  -21.6430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6192  -20.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8942  -20.4312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3202  -20.3816    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  4  6  2  0
  2  7  1  0
  1  8  1  1
 11 12  1  0
 11 13  1  0
 11 14  2  0
 12 15  1  0
 15 16  1  0
 15 17  1  6
 17 18  1  0
 17 19  1  0
 16 20  1  0
 16 21  2  0
 20 22  1  0
 22 23  1  0
 22 24  1  1
 23 25  2  0
 24 26  1  0
 26 27  1  0
 26 28  2  0
 23 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  6
 32 33  1  0
 32 34  1  0
 31 10  1  0
 31 35  2  0
 10 36  1  0
 10 37  1  0
 36 39  1  0
 40 37  1  0
 37  9  1  0
  9  8  1  0
  9 38  2  0
 41 39  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 40  1  0
 44 46  1  0
M  END

Associated Targets(Human)

CASP2 Tchem Caspase-2 (173 Activities)

Discover Target: CASP2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

CASP3 Tchem Caspase-3 (3632 Activities)

Discover Target: CASP3

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 710.58	Molecular Weight (Monoisotopic): 709.1959	AlogP: -0.11	#Rotatable Bonds: 12
Polar Surface Area: 220.54	Molecular Species: ACID	HBA: 9	HBD: 6
#RO5 Violations: 2	HBA (Lipinski): 15	HBD (Lipinski): 6	#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.25	CX Basic pKa: ┄	CX LogP: -0.03	CX LogD: -3.03
Aromatic Rings: 1	Heavy Atoms: 46	QED Weighted: 0.16	Np Likeness Score: 0.16

References

1. Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M, Muñoz-Sanjuán I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C.. (2011) Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors., 19 (19): [PMID:21903398] [10.1016/j.bmc.2011.08.020]
2. Chen, Yi-Hua YH and 9 more authors. 2006-03-09 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. [PMID:16509578]
3. Maillard, Michel C MC and 17 more authors. 2011-10-01 Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. [PMID:21903398]

R/S-(S)-3-((S)-2-Acetylamino-3-methyl-butyrylamino)-N-{(S)-1-[7-bromo-1-((S)-2-hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-2-methyl-propyl}-succinamic acid

Names and Identifiers

Alternative Forms

Associated Targets(Human)

Molecule Features

Drug Indications

Mechanisms of Action

Biocomponents

Calculated Properties

References

Source